TCM
DERM

TimesSquare Capital Management’s Dermira, Inc. DERM Stock Holding History

TimesSquare Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,277,527
Closed -$61.5M – 263
2017
Q3 		$61.5M Sell
2,277,527
-249,700
-10% -$6.53M 0.41% 92
2017
Q2 		$73.6M Sell
2,527,227
-61,434
-2% -$1.87M 0.47% 77
2017
Q1 		$88.3M Buy
2,588,661
+164,950
+7% +$5.32M 0.57% 53
2016
Q4 		$73.5M Buy
2,423,711
+144,400
+6% +$4.65M 0.49% 71
2016
Q3 		$77.1M Sell
2,279,311
-212,215
-9% -$6.83M 0.5% 71
2016
Q2 		$72.9M Buy
2,491,526
+1,101,645
+79% +$30.4M 0.48% 78
2016
Q1 		$28.7M Buy
1,389,881
+319,705
+30% +$7.84M 0.19% 183
2015
Q4 		$37M Buy
1,070,176
+243,600
+29% +$6.99M 0.23% 166
2015
Q3 		$19.3M Buy
+826,576
New +$20.1M 0.12% 204

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TimesSquare Capital Management's DERM Position: Q4 2017 in Review

TimesSquare Capital Management sold out of Dermira, Inc. (DERM) in Q4 2017, closing a stake of 2,277,527 shares — an estimated $61.5M sold.

TimesSquare Capital Management first reported a position in DERM in Q3 2015 and held it in 9 quarters. The position peaked at $88.3M in Q1 2017. 126 funds tracked by Wall St. Rank hold DERM as of Q4 2017.

  • TimesSquare Capital Management reported no remaining Dermira, Inc. position as of Q4 2017 after selling out during the quarter.
  • TimesSquare Capital Management sold 2,277,527 Dermira, Inc. shares in Q4 2017, an estimated $61.5M.
  • TimesSquare Capital Management first reported a position in Dermira, Inc. in Q3 2015 and held it in 9 quarters.
  • TimesSquare Capital Management's Dermira, Inc. position peaked at $88.3M in Q1 2017.
  • 126 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2017.

Based on TimesSquare Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.